News

Eli Lilly has agreed to acquire cardiovascular disease treatment specialist Verve Therapeutics in a deal potentially rising ...
Supply chains for a new generation of therapies are complex, costly, and require meticulous management to ensure patient ...
The European Commission (EC) has granted marketing authorisation for Averoa's oral therapy Xoanacyl for chronic kidney ...
European biotechs have historically struggled to find capital on the continent, but the funding ecosystem now aims to scale ...
Sweeping changes made by RFK Jr at the CDC have weakened the US's immunisation programme, according to former ACIP members.
Teva Pharmaceutical has announced a collaboration with Fosun Pharma to advance the global development of the ATTENUKINE ...